Abstract:BACKGROUND Coagulation factor XIIIa(FXIIIa) plays a critical role in the final stage of blood coagulation. It is extremely important in wound healing, tissue repairing and promoting cell adhesion. The deficiency of the coagulation factor can cause hemorrhage and slow wound healing. OBJECTIVE In this study, recombinant pPICZαC-FXIIIa was expressed in Pichia pastoris, purified as well as its biological activity was determined. METHODS The FXIIIa fragment obtained from the human placenta was inserted into pPICZαC to obtain pPICZαC-FXIIIa, which was transformed into X33 after linearization, and FXIIIa inserted into Pichia pastoris X33 was screened for methanol induction. The expressed product was identified by western blotting, then the supernatant was purified by affinity chromatography, and the purified product was determined by plasma coagulation experiment. RESULTS Polymerase Chain Reaction(PCR) showed that the FXIIIa fragment of 2250 bp was inserted successfully into pPICZαC. The expression and purification products of the same molecular weight as target protein(about 83 kDa) were obtained, which solidified significantly when reacted with plasma. CONCLUSION The expression and purification products were successful, with sufficient biological activity, which can be used as a candidate FXIIIa hemostatic agent in genetic engineering.

Research on Optimum Fermentation Condition of Recombined Human Antithrombin

Optimization of fermentation conditions for xylanase production by engineered Pichia pastoris

The Research on Optimal Culture Condition of Recombintant Chitinase Production in Pichia pastoris

Studies on the Fermentation Condition Optimization of Fibrinolytic Enzyme Produced by Armiilaria Luteo-virens Sacc

Efficient expression and purification of recombinant alcohol oxidase in Pichia pastoris

Optimization of Condition for Expression of Recombinant ChMIL18-HN in Pichia Pastoris

Optimization of Cultivation Conditions of Recombinant Escherichia Coli Strain Expressing Human Anticoagulant Protein(rHAP)

Optimization of medium composition and inducing pH of porcine insulin precursor fermentation by recombinant Pichia pastoris using of central composite design

Study on Fermentation Conditions and Reaction Conditions of Phonphatidylserine Synthase

Expression, Purification and Characterization of Recombinant Human Coagulation Factor XIIIa in Pichia Pastoris

Optimization of Expression Conditions of Hybrid Antimicrobial Peptide LPCB in Pichia Pastoris

[Studies on the Expression Condition of Human Trefoil Factor 3 in Pichia Pastoris].

An Optimized Fermentation and Purification Process for a Recombinant Human Antibody ScFv-Fc Fragment Expressed in Pichia Pastoris

Study on the Expression System of Human Acetaldehyde Dehydrogenase 2 Gene in Pichia SMD1168

Culture Conditions Affecting High Level Expression of Porcine Insulin Precursor (PIP) by Recombinant Pichia Pastoris in High Cell Density Fermentation

[High Efficient Expression of Recombinant Human Platelet Factor IV in Pichia Pastoris].

Optimization of Conditions to Stabilize and Maximize Pichia Pastoris Fermentation of Human Lysozyme - Tachyplesin Ⅰ Fusion Protein

Optimization of Fermentation Conditions of Genetically Engineered Pichia pastoris Expressing Recombinant Human-source Collagen

Optimization of Conditions to Stabilize and Maximize Pichia Pastoris Fermentation of Recombinant Mutant Interleukin-2

Investigation of Fermentation Conditions of Recombinant Consensus Interferon in E.coli

Production and Optimization of Recombinant Human Augmenter of Liver Regeneration by Pichia Pastoris